IL147332A0 - Orally active androgens - Google Patents

Orally active androgens

Info

Publication number
IL147332A0
IL147332A0 IL14733200A IL14733200A IL147332A0 IL 147332 A0 IL147332 A0 IL 147332A0 IL 14733200 A IL14733200 A IL 14733200A IL 14733200 A IL14733200 A IL 14733200A IL 147332 A0 IL147332 A0 IL 147332A0
Authority
IL
Israel
Prior art keywords
orally active
active androgens
androgens
orally
active
Prior art date
Application number
IL14733200A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL147332A0 publication Critical patent/IL147332A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL14733200A 1999-07-16 2000-07-10 Orally active androgens IL147332A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99202348 1999-07-16
PCT/EP2000/006544 WO2001005806A1 (en) 1999-07-16 2000-07-10 Orally active androgens

Publications (1)

Publication Number Publication Date
IL147332A0 true IL147332A0 (en) 2002-08-14

Family

ID=8240463

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14733200A IL147332A0 (en) 1999-07-16 2000-07-10 Orally active androgens

Country Status (28)

Country Link
US (3) US6313108B1 (de)
EP (1) EP1203011B1 (de)
JP (1) JP2003505394A (de)
KR (1) KR20020092890A (de)
CN (1) CN1360589A (de)
AR (1) AR024746A1 (de)
AT (1) ATE257159T1 (de)
AU (1) AU770412B2 (de)
BR (1) BR0012489A (de)
CA (1) CA2379223A1 (de)
CO (1) CO5200765A1 (de)
CZ (1) CZ2002192A3 (de)
DE (1) DE60007530T2 (de)
ES (1) ES2213596T3 (de)
HK (1) HK1043797A1 (de)
HU (1) HUP0201952A3 (de)
IL (1) IL147332A0 (de)
MX (1) MXPA02000601A (de)
NO (1) NO20020222L (de)
NZ (1) NZ516525A (de)
PE (1) PE20010330A1 (de)
PL (1) PL353007A1 (de)
RU (1) RU2002103883A (de)
SK (1) SK712002A3 (de)
TR (1) TR200200076T2 (de)
TW (1) TW548277B (de)
WO (1) WO2001005806A1 (de)
ZA (1) ZA200200106B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE246703T1 (de) * 1999-04-06 2003-08-15 Akzo Nobel Nv Oral wirksame 7-alpha-alkyl androgene
US20030069215A1 (en) * 2001-03-30 2003-04-10 The Government Of The United States Of America, Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate
ATE334682T1 (de) * 2000-03-31 2006-08-15 Us Gov Health & Human Serv Verfahren zur herstellung von den trans-4-n- butylcyclohexanoicsaüre- und undecanoicsaüreestern von (7-alpha,11-beta)- dimethyl-17 beta -hydroxy-4-estren-3-one und deren medizynische anwendung
AU8201601A (en) * 2000-07-28 2002-02-13 Akzo Nobel Nv 16alpha-methyl or ethyl substituted estrogens
DK1379253T3 (da) * 2001-03-30 2006-06-26 Us Gov Health & Human Serv Fremgangsmåde til fremstilling og anvendelse af farmaceutiske formuleringer omfattende 7alfa, 11beta-dimethyl-17beta-hydroxyestra-4, 14-dien-3-on og 17-estere heraf
WO2003059931A1 (en) * 2002-01-21 2003-07-24 Akzo Nobel N.V. PROCESS FOR THE PREPARATION OF 7α-METHYLSTEROIDS
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
PE20050677A1 (es) 2003-12-22 2005-10-04 Akzo Nobel Nv Esteroides con perfil androgenico y progestagenico mixto
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
WO2010043404A1 (en) * 2008-10-15 2010-04-22 Synthon B.V. Processes and intermediates for the production of fulvestrant
HUE029252T2 (en) 2011-06-01 2017-02-28 Estetra Sprl Process for the preparation of intermediates of estetrol
SG195121A1 (en) * 2011-06-01 2013-12-30 Estetra S A Process for the production of estetrol intermediates
EP2383279A1 (de) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Herstellungsverfahren für Esterol
EP2764008B1 (de) * 2011-10-07 2016-08-17 Estetra S.P.R.L. Verfahren zur herstellung von estetrol
WO2015181116A1 (en) 2014-05-26 2015-12-03 Crystal Pharma, S.A.U. Process and intermediades for the preparation of 7-alkylated steroids
CN116077454A (zh) 2015-06-18 2023-05-09 埃斯特拉有限责任公司 含雌四醇组分的口腔分散剂量单位
RS61777B1 (sr) 2015-06-18 2021-06-30 Estetra Sprl Oralno-disperzibilna tableta koja sadrži estetrol
HUE054589T2 (hu) 2015-06-18 2021-09-28 Estetra Sprl Szájban diszpergálódó esztetrol tartalmú tabletta
MD3310333T2 (ro) 2015-06-18 2020-06-30 Estetra Sprl Unitate de dozare orodispersabilă care conține un component estetrol
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
ES2906117T3 (es) * 2017-02-23 2022-04-13 Siemens Healthcare Diagnostics Inc Conjugados de androstenodiona quimioluminiscente
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
DK3781171T3 (da) 2018-04-19 2022-05-02 Estetra Srl Sammensætninger og deres anvendelser til lindring af menopause-associerede symptomer
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA712312B (en) * 1970-04-28 1972-01-26 Ochsner Med Found Alton 4,14-estradiene compounds

Also Published As

Publication number Publication date
CA2379223A1 (en) 2001-01-25
HUP0201952A2 (en) 2002-10-28
BR0012489A (pt) 2002-04-02
US20030087886A1 (en) 2003-05-08
US6780854B2 (en) 2004-08-24
US6313108B1 (en) 2001-11-06
PL353007A1 (en) 2003-09-22
CN1360589A (zh) 2002-07-24
TW548277B (en) 2003-08-21
ES2213596T3 (es) 2004-09-01
AU770412B2 (en) 2004-02-19
AR024746A1 (es) 2002-10-23
KR20020092890A (ko) 2002-12-12
DE60007530T2 (de) 2004-12-23
CZ2002192A3 (cs) 2002-06-12
HK1043797A1 (zh) 2002-09-27
US20020022609A1 (en) 2002-02-21
SK712002A3 (en) 2002-06-04
PE20010330A1 (es) 2001-03-22
CO5200765A1 (es) 2002-09-27
US6541465B2 (en) 2003-04-01
WO2001005806A1 (en) 2001-01-25
ZA200200106B (en) 2003-06-25
TR200200076T2 (tr) 2002-04-22
NO20020222L (no) 2002-01-25
JP2003505394A (ja) 2003-02-12
DE60007530D1 (de) 2004-02-05
NO20020222D0 (no) 2002-01-15
ATE257159T1 (de) 2004-01-15
NZ516525A (en) 2003-06-30
EP1203011A1 (de) 2002-05-08
RU2002103883A (ru) 2004-02-27
AU6562900A (en) 2001-02-05
HUP0201952A3 (en) 2003-10-28
MXPA02000601A (es) 2002-07-30
EP1203011B1 (de) 2004-01-02

Similar Documents

Publication Publication Date Title
IL147332A0 (en) Orally active androgens
EG24411A (en) Pharmaceutically active compounds
GB9924020D0 (en) Pharmaceutically active compounds
IL146117A0 (en) New pharmaceutically active compounds
PL342012A1 (en) Pharmacologically active morpholinol
AU142262S (en) Towel
IL130796A (en) Packet processor
GB9910227D0 (en) Fixed wrench
IL147216A0 (en) Arylsulfonamido-substituted hydroxamic acid derivatives
GB0021654D0 (en) Not available at present
GB9929979D0 (en) Hydroxamic acid derivatives
PL365748A1 (en) Roll
GB0017822D0 (en) Pharmaceutically active compound
GB9926630D0 (en) Pharmacologically active compounds
CA86215S (en) Towel
CA86214S (en) Towel
GB9901444D0 (en) Anti-inflammatory agents
IL144237A0 (en) Organoprotective solutions
GB9924028D0 (en) Pharmaceutically active compounds
GB9924041D0 (en) Pharmaceutically active compounds
GB9924063D0 (en) Pharmaceutically active compounds
TW405495U (en) Improvement of wrench structure
GB0018660D0 (en) Pharmaceutically active compounds
GB0018656D0 (en) Pharmaceutically active compounds
GB0007345D0 (en) Pharmaceutically active compounds